Results

Total Results: 1,424 records

Showing results for "topical treatment".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0371_11-23-2010.pdf
    January 01, 2010 - measures or performance metrics, especially when gathered longitudinally over the long term, improves treatment … Outcome(s): Improvements in treatment results for patients (these results could be measured using patient-centered … clinicians treat patients, and changes in the manner in which the healthcare system approaches the treatment
  2. effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Off-label intranasal oxytocin for treatment of autism spectrum disorders No high-impact potential … Presently, behavioral therapies and pharmaceutical treatments are used to improve various symptoms … ES-3 Eligible Topic Not Deemed High Impact  Off-label intranasal oxytocin for treatment of autism
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-266-cdd-executive-summary.pdf
    November 01, 2023 - Comparative Effectiveness Review No. 266_Cervical Degenerative Disease Treatment: A Systematic Review … Comparative Effectiveness Review Number 266 Cervical Degenerative Disease Treatment: A Systematic … 2 Background and Purpose This systematic review identifies and synthesizes research on treatments … and 1980 for nonoperative treatment to February 15, 2023. … Cervical Degenerative Disease Treatment: A Systematic Review.
  4. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Better treatments to prevent COPD exacerbations are needed. … Although the cost of azithromycin therapy would be added to current treatment costs, its low cost and … Available: http://www.cff.org/treatments/CFCareGuidelines/. 30. Expert Commenter 665.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
    November 01, 2012 - Nonpharmacologic Therapies Four small, short-term studies assessed nonpharmacologic therapies in adults … One low-quality RCT evaluated near-infrared light therapy compared with sham treatment. … However, adverse effects of pharmacologic therapies and long-term treatment withdrawals due to adverse … • Randomized trials of nonpharmacologic treatments including herbal therapy, mind-body medicine, and … characteristics, such as disease duration and previous therapy, affect treatment outcomes
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/point-of-care_research.pdf
    April 01, 2014 - Systematic review: nonoperative and operative treatments for rotator cuff tears. … Systematic review: nonoperative and operative treatments for rotator cuff tears. … Lipid-lowering pharm therapy overview [4/7/2013] J Treatment of lipids - secondary prevention … Systematic review: nonoperative and operative treatments for rotator cuff tears. … Allergic rhinitis1 [7/24/2013] Immuno- therapy Treatment for Allergic Rhinitis [7/2013] Allergen
  7. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … unmet need for new therapeutic options for patients with IBS. … options, alternative therapies are needed. … FDA approves two therapies to treat IBS-D. [internet]. Silver Spring (MD): U.S.
  8. effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
    December 22, 2014 - market for HCV treatments. … The high cost of emerging HCV therapies combined with the large population of patients requiring treatment … The high cost of emerging HCV therapies combined with the large population of patients requiring treatment … Janssen Therapeutics. … Titusville (NJ): Janssen Therapeutics; 2014 Nov. 44 p.
  9. effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
    January 28, 2016 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Sovaldi and Sovaldi combination therapies. … of This Intervention No FDA-approved vaccines or antiviral agents exist for EVD, although several therapeutic … SVR12 was 76% in patients naïve to treatment after 8 weeks of therapy.
  10. effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
    January 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Mesenchymal stem cell therapy for treatment of osteoarthritis 3. … = 0.043 and p = 0.010 respectively). 54 Autologous PRP is not currently considered a drug or a therapeutic … Gout therapeutics: new drugs for an old disease. Lancet 2011 Jan 8;377(9760):165-77.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
    August 31, 2017 - We have added a category for parent based treatments. … Per Key Question 2, harms were assessed for all treatments. … therapy consisted of. … psychotherapy” category due to the significant theoretical and methodological differences between these therapeutic … how I would have classified therapies.
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
    February 01, 2013 - myocardial infarction, and some data suggest that women and men may not respond equally to the same treatments … ; and the fifth gap (with its three subparts) looks at adverse effects that may occur due to these treatments … What are the risks, benefits, and costs of different treatments for CAD, stratified by gender? … type, and the potential harms in women of different treatments for stable and unstable angina. … Especially for patients treated with already approved treatments and whose clinical care is not affected
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
    September 01, 2010 - guidelines point to controversial areas in need of future research, including: treatments to achieve … versus initial combination therapy, we will collect data regarding prior therapy and will consider … analyzing those with and without prior therapy separately. … OR azathioprine[tiab] OR methotrexate[tiab] OR “6-mercaptopurine”[tiab] OR “antibodies, monoclonal/therapeutic … Prednisone Prednisolone 6-methylpredisolone Hydrocortisone Budesonide All trade names Oral, topical
  14. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
    January 01, 2015 - therapeutic effects and better glycemic control. … The mode of delivery, an implanted pump, is an established therapy for other drugs or other treatments … Unlike other treatments for T2DM, management of therapy with the ITCA 650 is controlled by the device … , corticosteroids, or anti-VEGF therapies, making this new intervention just another treatment option … Investigational therapeutic options in the management of DME: investigational pharmacologic treatments
  15. effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … established for predicting development of dementia or other neurologic condition or monitoring responses to therapies … this test is able to rule out AD), reduced need for long- term care, and avoided use of ineffective therapies … Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
    November 19, 2012 - Testing and Treatment Treatment for CUR is dependent on etiology. … , and pharmacologic treatments. … Table 1 lists the various surgical and nonsurgical treatments for CUR. … silodosin); 5-Alpha Reductase Inhibitors (5-ARI): dutasteride, finasteride; AB + 5- ARI combination therapy … duration Setting Any treatment setting.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
    January 01, 2008 -  Due to the large number of diseases for which HSCT is a treatment option (or experimental therapy … Given the cost of treatment, the severity of diseases that HSCT is used to treat, and the prevalence
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rotator-cuff-tears-future_research.pdf
    February 01, 2013 - and between various nonoperative therapies. … , and between various nonoperative therapies. … Operative treatment NSAID Corticosteroid injection Physical therapy Modalities Others … Treatments include but are not limited to: exercise, manual therapy, cortisone injections, acupuncture … and between various nonoperative therapies.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0355_09-22-2010.pdf
    January 01, 2010 - benzodiazepine receptor agonists, or antidepressants), complementary and alternative care, relaxation therapy … , cognitive behavioral therapy, hormones Comparator(s): Placebo or comparison to another insomnia … Treatment of chronic insomnia is a dilemma commonly encountered in primary care. … medications are most effective and when medications should be used as opposed to nonpharmacologic treatments
  20. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Because of even greater morbidity risk, therapeutic intervention is considered to be urgently needed … In September 2014, FDA approved naltrexone-bupropion (Contrave®, Orexigen Therapeutics, Inc., La Jolla … A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011 Nov;74(5):943-53.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: